CANCIDAS

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Ireland, Japan, Lithuania, Mexico, Nigeria, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CANCIDAS contains one active pharmaceutical ingredient (API):

1 Caspofungin UNII VUW370O5QE - CASPOFUNGIN ACETATE

Caspofungin acetate is a semi-synthetic lipopeptide (echinocandin) compound synthesised from a fermentation product of Glarea lozoyensis. Caspofungin acetate inhibits the synthesis of beta (1,3)-D-glucan, an essential component of the cell wall of many filamentous fungi and yeast. Beta (1,3)-D-glucan is not present in mammalian cells. Read about Caspofungin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CANCIDAS Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J02AX04	Caspofungin	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525500301155311, 525500302151318
Country: CA	Health Products and Food Branch	Identifier(s): 02244265, 02244266
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30028-11-11, 30033-11-11
Country: EE	Ravimiamet	Identifier(s): 1087477, 1092169
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 01196001, 01196003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 006079, 006115
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 48475
Country: JP	医薬品医療機器総合機構	Identifier(s): 6179402D1020, 6179402D2026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007521, 1028063
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 555M2000
Country: NG	Registered Drug Product Database	Identifier(s): B4-9092, B4-9093
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 70300, 70319
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100126880, 100126896
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64792001, W64793001
Country: SG	Health Sciences Authority	Identifier(s): 11762P, 11763P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7013131H, 7013132H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636260203, 8699636260227
Country: US	FDA, National Drug Code	Identifier(s): 0006-3822, 0006-3823
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/20.2.2/0544, 37/20.2.2/0545